Allarity Therapeutics, Inc. Increase (Decrease) in Contract with Customer, Liability
Allarity Therapeutics, Inc. (ALLR) reported Increase (Decrease) in Contract with Customer, Liability of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-03-30
- Allarity Therapeutics, Inc. increase (decrease) in contract with customer, liability for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Allarity Therapeutics, Inc. increase (decrease) in contract with customer, liability for fiscal 2024 was $207.00K.
- Allarity Therapeutics, Inc. increase (decrease) in contract with customer, liability for fiscal 2023 was $0.00.
| Period end | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-30 |
| 2024-12-31 | $207.00K 10-K · filed 2026-03-30 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |